Quarterly 4C out and not on last day, page-50

Hi Jase recently you posted:

'By my calculations 27 July is the date at which 90 days expires (the time the parties promised each other to formalize legally binding licences agreements). Others have suggested that this calculation might be too early, and the 90 days could actually expire in early August. I don't agree,'

...and Oggy posted:

'By 28 July (Expiry of 90 days period) the licenses will be assigned with the global launch'

Oggy now appears to have also now changed tune as of today:

'I predict between now and 4 August 2016 the company will be in trading halt with regard to the formal licenses and orders. It seems logical to me given the past announcements.'



I still stand by my previous analogy of the announcement of 27/4 over the one on 28/4; and referring to the 27/4 announcement:

'A detailed licensing agreement will be finalised within 90 days of the execution of the Term Sheet'

http://www.asx.com.au/asxpdf/20160427/pdf/436s0472z5zdqy.pdf

As you know, the Term Sheets were officially executed @ 12.08pm on the 6th of May + 90 days = 03\08 as a maximum, but may come any day prior.

So imo, according to the two conflicted announcements of 27/28 April, the cut-off could be either 28/04 or 03/08.



Add to the above analogy, the Olympics are due to kick off on 05/08/2016, the formal Licensing Agreements imo could be expected prior to Olympics kick-off for another perfect alignment and Marketing opportunity that P&G would be cra cra to let slip by.

Also, on August 2 2016 (August 03 2016 Australian time and another perfect alignment):

'The Procter & Gamble Company (NYSEG) will webcast a discussion of its fourth quarter earnings results on Tuesday, August 2, 2016 beginning at 8:30 a.m. ET.
Media and investors may access the live audio webcast at www.pginvestor.com, beginning at 8:30 a.m. ET. The webcast will also be available for replay.'





OBJ Shareholder Update June 2016 Pros & Cons:





- Pros -





P&G:

'OBJ greatly values its very fruitful and growing relationship with P&G.'

'expanded to accommodate P&G’s evaluation of new OBJ innovations.'

'The PDA includes the over-arching multi-product and multi-category terms of license agreements that have emerged from development programs undertaken by OBJ while being funded by P&G.'

'The Wave I Eye Wand...a mainstream product offering in SK-II’s global business. OBJ also recently announced the agreement for the Term Sheet for the second licensed product for P&G that incorporates OBJ’s technology.'

'Eleven Work Plans...Additional Work Plans are currently in negotiation.'

'The new PDA also focuses on the partnership for strategic areas for P&G. This will allow OBJ to seek new partnering opportunities in several product categories not currently under active development with P&G. '

'OBJ also held discussions with P&G’s brands for the next steps in shaving following the successful testing undertaken during 2015.'


Coty:

'OBJ has been informed that Coty will now compile their assessment of their test results and analyse these before reverting back to OBJ.'


Bodyguard:

'refining the complex manufacturing requirements for the first KneeGuard product and the forthcoming “hot dot” general BodyGuard product designs.'

'...an important IP consideration with prospective licensees.'

'Discussions with potential licensees continue as planned, in both Europe and the USA over the July period.'

'Discussions have moved a step closer with two potential Licensees for BodyGuard expressing strong interest in the entire product portfolio. The Board remains very pleased with progress in both the manufacturability of the product range as well as the potential distributor discussions.'


Surface Hygiene:

'This opportunity has gained much traction over the period as it would appear the OBJ approach could be quite significant in dealing with growing resistance to various surface treatments using commonly available disinfectants as advised by potential partnering companies.'

'...targeted distribution companies..


Personalised Skincare:

'Advanced discussions are underway regarding the commencement of a consumer trial in Asia with a major FMCG company to evaluate consumer behaviour remotely using the OBJ dermaportation and skin personalising software and processing.'

'This will be an important precursor for an expected formal development of the entire personalisation approach with a partnering company.'

'...discussions with the major FMCG company has vindicated the direction and investment made to date in approaching the commercialisation of the dermaportation technology and additional discussions continue to take place with other FMCG companies on the same application.'


Advanced Packaging:

'The first potential application for incorporating OBJ’s technologies (DCE) into existing packaging, thereby enhancing a product’s performance, is under evaluation with several of our global FMCG partners. This opportunity has expanded across multiple applications and device configurations. Several meetings are planned with a major FMCG company during July on the possible next steps for one of the skin care applications.'

'...OBJ has the potential to access a whole new area of revenue opportunities with its own packaging solutions.'





- Cons -

Not all will consider the below as Cons, albeit it still constituting further OBJ expenditure.

Although OBJ relationship with P&G is fully funded as announced 'The Company’s cash management remains strictly controlled with a balance of $7.33m at 30 June 2016.', there will be new expenditure moving forward for in-house growth of OBJ funded programs:

'Over the period, the Company continued to invest considerable time and expenditure working with its US consultants in refining the complex manufacturing requirements for the first KneeGuard product and the forthcoming “hot dot” general BodyGuard product designs.'

'...agreement on a performance-linked consulting contract with Steve Meller...'

'OBJ has upgraded its skin laboratory with a commitment to expand its laboratory space and acquire an additional mass spectrometer'

'The case involving the convertible note from Monarch that expired in June 2012 continues in the Supreme Court and the Company has retained legal counsel as appropriate.'




On the down-low, I received an email last week from Olay asking me to 'take part in one of our most exciting innovations in skincare'. It involves taking a selfie and answering 4 questions. Although I didn't qualify due to my age and sex (I presume), the email stated 'Help Olay give millions of women the best skincare experience. With your selfie, you can help us build our smartest skincare analysis tool. Be part of the innovation!' Could P&G be the FMCG that OBJ are referring to under Personalised Skin Care for the Consumer Trial? Stay tuned!




All in all, I agree with Jase that there is alot of 'repeated (albeit positive) vague waffle', with some added progress.

Keep an eye out for P&G's expected multiple formal Product Licensing Agreements anytime from now until AUGUST 03 2016 .